Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 11721-11730 of 13618

Page
per page
  1. Avasimibe
    A4318 Avasimibe
    Target: Acyl coenzyme A: cholesterol acyltransferases
    Summary: ACAT inhibitor,orally bioavailable
      ≥25.09 mg/mL
  2. Mycophenolate Mofetil
    A4336 Mycophenolate Mofetil
    Summary: IMPDH inhibitor
  3. Tioxolone
    A4362 Tioxolone
    Target: Carbonic Anhydrases
    Summary: CAI inhibitor
      ≥63.2 mg/mL
  4. Pravastatin sodium
    A4369 Pravastatin sodium
     2 Citation
    Target: HMG-CoA Reductases
    Summary: HMG-CoA reductase inhibitor,highly selective and competitive
  5. Tolcapone
    A4383 Tolcapone
    Target: Catechol O-Methyltransferase (COMT)
    Summary: COMT inhibitor
      insoluble in H2O; ≥12 mg/mL
  6. Z-DEVD-FMK
    A1920 Z-DEVD-FMK
     40 Citation
    Target: Caspases
    Summary: Caspase-3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥60 mg/mL
  7. Pemetrexed disodium
    A4390 Pemetrexed disodium
     1 Citation
    Target: Thymidylate Synthase|DHFR|GARFT
    Summary: TS, DHFR,GARFT and AICARFT inhibitor
      insoluble in EtOH; ≥15.68 mg/mL
  8. AKT inhibitor VIII
    A3149 AKT inhibitor VIII
     2 Citation
    Target: Akt
    Summary: Allosteric Akt kinase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.2 mg/mL
  9. ASC-J9
    A3190 ASC-J9
    Summary: AR degradation enhancer,antiumor agent
      insoluble in EtOH; insoluble in H2O; ≥16.65 mg/mL
  10. AT7519 Hydrochloride
    A3197 AT7519 Hydrochloride
    Target: Cyclin-Dependent Kinases
    Summary: Multi-CDK inhibitor
      ≥29.93 mg/mL

Items 11721-11730 of 13618

Page
per page